In addition, clinicopathological data pertaining to the patients included in this TMA were compiled, including age, gender, HBsAg, HBcAb, HCV, liver cirrhosis, total bilirubin level, ALT level, GGT level, cirrhotic nodules, vascular invasion, tumor number, tumor size, recrudescence, and AJCC TNM stage (Table 1). This evidence concerns the gene GPT and cirrhosis of liver.